Form 4 for XTNT Xtant Medical Holdings, Inc.

Accepted 2022-10-11 00:00:00 ET · period of report 2022-10-07 · accession 0001235802-22-000113 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2022-10-11	2022-10-07	XTNT	Vizirgianakis Stavros G.	Dir	P - Purchase	$0.48	+2.26M	5.85M	+63%	+$1.09M
D	2022-10-11	2022-10-07	XTNT	Vizirgianakis Stavros G.	Dir	P - Purchase	$0.00	+566.2K	566.2K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock, $0.000001 par value	2022-10-07	P	A	2,264,861	$0.48	5,850,716	D	—	—	(F1) These shares were issued in a second and final tranche of a private placement pursuant to a securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors. (F2) Includes 70,776 shares to be issued upon vesting pursuant to a restricted stock unit award granted under the Xtant Medical Holdings, Inc. Amended and Restated 2018 Equity Incentive Plan, conditioned upon the reporting person remaining a director of Xtant through the vesting date.
2	Derivative	Warrant	2022-10-07	P	A	566,214	$0.00	566,214	D	$0.48 · 2022-10-07 to 2027-08-25	566,214 Common Stock	(F3) This warrant was issued in a second and final tranche of a private placement pursuant to the securities purchase agreement by and among Xtant Medical Holdings, Inc. and several accredited investors. (F4) This total does not include a warrant to purchase 878,770 shares of common stock issued on August 25, 2022. Such warrant was immediately exercisable as of the date of issuance and previously reported by the Reporting Person on a Form 4 filed with the Securities and Exchange Commission on August 26, 2022.